These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 8663424

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1.
    Landgren E, Schiller P, Cao Y, Claesson-Welsh L.
    Oncogene; 1998 Jan 22; 16(3):359-67. PubMed ID: 9467961
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization.
    Viglietto G, Romano A, Manzo G, Chiappetta G, Paoletti I, Califano D, Galati MG, Mauriello V, Bruni P, Lago CT, Fusco A, Persico MG.
    Oncogene; 1997 Nov 27; 15(22):2687-98. PubMed ID: 9400995
    [Abstract] [Full Text] [Related]

  • 5. Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell lines.
    Viglietto G, Maglione D, Rambaldi M, Cerutti J, Romano A, Trapasso F, Fedele M, Ippolito P, Chiappetta G, Botti G.
    Oncogene; 1995 Oct 19; 11(8):1569-79. PubMed ID: 7478581
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D, Jimenez X, Zhang H, Wu Y, Bohlen P, Witte L, Zhu Z.
    Cancer Res; 2001 Oct 01; 61(19):7002-8. PubMed ID: 11585724
    [Abstract] [Full Text] [Related]

  • 9. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR.
    Park JE, Chen HH, Winer J, Houck KA, Ferrara N.
    J Biol Chem; 1994 Oct 14; 269(41):25646-54. PubMed ID: 7929268
    [Abstract] [Full Text] [Related]

  • 10. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR.
    Cao Y, Chen H, Zhou L, Chiang MK, Anand-Apte B, Weatherbee JA, Wang Y, Fang F, Flanagan JG, Tsang ML.
    J Biol Chem; 1996 Feb 09; 271(6):3154-62. PubMed ID: 8621715
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast.
    Shore VH, Wang TH, Wang CL, Torry RJ, Caudle MR, Torry DS.
    Placenta; 1997 Nov 09; 18(8):657-65. PubMed ID: 9364601
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor.
    Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH.
    J Biol Chem; 1994 Oct 28; 269(43):26988-95. PubMed ID: 7929439
    [Abstract] [Full Text] [Related]

  • 15. Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (PlGF) in regulating human haemopoietic cell growth.
    Ratajczak MZ, Ratajczak J, Machalinski B, Majka M, Marlicz W, Carter A, Pietrzkowski Z, Gewirtz AM.
    Br J Haematol; 1998 Dec 28; 103(4):969-79. PubMed ID: 9886308
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical detection of vascular endothelial growth factor (VEGF) and VEGF receptors Flt-1 and KDR/Flk-1 in the cochlea of guinea pigs.
    Michel O, Hess A, Bloch W, Schmidt A, Stennert E, Addicks K.
    Hear Res; 2001 May 28; 155(1-2):175-80. PubMed ID: 11335087
    [Abstract] [Full Text] [Related]

  • 17. Cyclic changes in expression of mRNA of vascular endothelial growth factor, its receptors Flt-1 and KDR/Flk-1, and Ets-1 in human corpora lutea.
    Endo T, Kitajima Y, Nishikawa A, Manase K, Shibuya M, Kudo R.
    Fertil Steril; 2001 Oct 28; 76(4):762-8. PubMed ID: 11591411
    [Abstract] [Full Text] [Related]

  • 18. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.
    Seetharam L, Gotoh N, Maru Y, Neufeld G, Yamaguchi S, Shibuya M.
    Oncogene; 1995 Jan 05; 10(1):135-47. PubMed ID: 7824266
    [Abstract] [Full Text] [Related]

  • 19. Tumor-specific regulation of angiogenic growth factors and their receptors during recovery from cytotoxic therapy.
    Taylor AP, Osorio L, Craig R, Raleigh JA, Ying Z, Goldenberg DM, Blumenthal RD.
    Clin Cancer Res; 2002 Apr 05; 8(4):1213-22. PubMed ID: 11948135
    [Abstract] [Full Text] [Related]

  • 20. A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3'-kinase activation and endothelial cell migration.
    Gille H, Kowalski J, Yu L, Chen H, Pisabarro MT, Davis-Smyth T, Ferrara N.
    EMBO J; 2000 Aug 01; 19(15):4064-73. PubMed ID: 10921887
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.